Literature DB >> 8636124

p150TSP, a conserved nuclear phosphoprotein that contains multiple tetratricopeptide repeats and binds specifically to SH2 domains.

S N Malek1, C H Yang, W C Earnshaw, C A Kozak, S Desiderio.   

Abstract

Src homology 2 (SH2) domains are structural modules that function in the assembly of multicomponent signaling complexes by binding to specific phosphopeptides. The tetratricopeptide repeat (TPR) is a distinct structural motif that has been suggested to mediate protein-protein interactions. Among SH2-binding phosphoproteins purified from the mouse B cell lymphoma A20, a 150-kDa species was identified and the corresponding complementary DNA (cDNA) was molecularly cloned. This protein encoded by this cDNA, which we have termed p150TSP (for TPR-containing, SH2-binding phosphoprotein), is located predominantly in the nucleus and is highly conserved in evolution. The gene encoding p150TSP (Tsp) was mapped to chromosome 7 of the mouse with gene order: centromere-Tyr-Wnt11-Tsp-Zp2. The amino-terminal two-thirds of p150TSP consist almost entirely of tandemly arranged TPR units, which mediate specific, homotypic protein interactions in transfected cells. The carboxyl-terminal third of p150TSP, which is serine- and glutamic acid-rich, is essential for SH2 binding; this interaction is dependent on serine/threonine phosphorylation but independent of tyrosine phosphorylation. The sequence and binding properties of p150TSP suggest that it may mediate interactions between TPR-containing and SH2-containing proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636124     DOI: 10.1074/jbc.271.12.6952

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  DSIF, the Paf1 complex, and Tat-SF1 have nonredundant, cooperative roles in RNA polymerase II elongation.

Authors:  Yexi Chen; Yuki Yamaguchi; Yuta Tsugeno; Junichi Yamamoto; Tomoko Yamada; Mitsuhiro Nakamura; Koji Hisatake; Hiroshi Handa
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

2.  Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane.

Authors:  Stéphanie De Gois; Patrick Slama; Nicolas Pietrancosta; Amaia M Erdozain; Franck Louis; Caroline Bouvrais-Veret; Laurent Daviet; Bruno Giros
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

3.  A tetratricopeptide repeat mutation in yeast transcription factor IIIC131 (TFIIIC131) facilitates recruitment of TFIIB-related factor TFIIIB70.

Authors:  R D Moir; I Sethy-Coraci; K Puglia; M D Librizzi; I M Willis
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

4.  Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.

Authors:  C C Smith; J Nelson; L Aurelian; M Gober; B B Goswami
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  The parafibromin tumor suppressor protein is part of a human Paf1 complex.

Authors:  Orit Rozenblatt-Rosen; Christina M Hughes; Suraj J Nannepaga; Kalai Selvi Shanmugam; Terry D Copeland; Tad Guszczynski; James H Resau; Matthew Meyerson
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  CDP1, a novel Saccharomyces cerevisiae gene required for proper nuclear division and chromosome segregation.

Authors:  P K Foreman; R W Davis
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

7.  A mechanism related to the yeast transcriptional regulator Paf1c is required for expression of the Arabidopsis FLC/MAF MADS box gene family.

Authors:  Sookyung Oh; Hua Zhang; Philip Ludwig; Steven van Nocker
Journal:  Plant Cell       Date:  2004-10-07       Impact factor: 11.277

8.  CTR9, a component of PAF complex, controls elongation block at the c-Fos locus via signal-dependent regulation of chromatin-bound NELF dissociation.

Authors:  Hyun-Seok Yoo; Jung-Hwa Seo; Joo-Yeon Yoo
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.